Citation Impact
Citing Papers
Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
2009 Standout
An Overview of Cyclophosphamide and Ifosfamide Pharmacology
1997
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans
2013 Standout
Reperfusion Injury of the Liver: Role of Mitochondria and Protection by Glutathione Ester
1999
Enhancement and Modification of Etoposide Release from Crospovidone Particles Loaded with Oil-Surfactant Blends
1997
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Toxoplasmosis
2004 Standout
Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature
2002
Gender difference in ifosfamide metabolism by human liver microsomes
2001
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
Cyclophosphamide and related anticancer drugs
2001
Treatment of oral candidiasis with methylene blue-mediated photodynamic therapy in an immunodeficient murine model
2002
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Relation Between the Turnover Number for Vinblastine Transport and for Vinblastine-stimulated ATP Hydrolysis by Human P-glycoprotein
1997
High-Dose Folinic Acid and Fluorouracil With or Without Ifosfamide Is an Inactive Combination in Advanced Pancreatic Cancer
1996
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
2004 Standout
Glutathione levels in human tumors
2012
Recent advances in the discovery and development of topoisomerase inhibitors as antitumor agents
1997
Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects
2010
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Expression of xCT and activity of system xc− are regulated by NRF2 in human breast cancer cells in response to oxidative stress
2015
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas.
1995
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
The cellular and molecular basis of hyperthermia
2002 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses
2002
Anthrazykline in der Krebstherapie
1997 Standout
Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
2010
“Lest we forget you — methylene blue …”
2011
Anthracycline Antibiotics in Cancer Therapy
1994
Synthetic organic dyes as contaminants of the aquatic environment and their implications for ecosystems: A review
2020 Standout
Osteosarcoma treatment – Where do we stand? A state of the art review
2013 Standout
Determination of cyclophosphamide and its metabolites in human plasma by high-performance liquid chromatography–mass spectrometry
1999
Glutathione Metabolism and Its Implications for Health
2004 Standout
Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study.
1996
Fluorescent and colorimetric probes for detection of thiols
2010 Standout
[11] Redox potential of GSH/GSSG couple: Assay and biological significance
2002
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
2008 Standout
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Photodynamic therapy in the treatment of microbial infections: Basic principles and perspective applications
2006 Standout
Malignant Gliomas in Adults
2008 Standout
Analysis of anticancer drugs: A review
2011 Standout
A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC–ESI-QTOFMS-based metabolomics
2011
Oxidative Stress in Cancer
2020 Standout
Photodynamic therapy: a new antimicrobial approach to infectious disease?
2004 Standout
Cellular and molecular actions of Methylene Blue in the nervous system
2009
The role of glutathione in cancer
2004
TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents
2006 StandoutNobel
Is body composition an important variable in the pharmacokinetics of anticancer drugs?
1994
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The importance of glutathione in human disease
2003 Standout
High performance liquid chromatography analysis of MESNA (2‐mercaptoethane sulfonate) in biological samples using fluorescence detection
2004
Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature
2000
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine
1995
Photodynamic therapy for localized infections—State of the art
2009 Standout
Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study.
1994
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
2000
Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC–ESI-QTOFMS-based metabolomics
2010
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Neuroinflammation: the devil is in the details
2016 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
2005 Standout
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
1999 Standout
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
2014 Standout
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
2013 Standout
The Pharmacologic Basis of Ifosfamide Use in Adult Patients with Advanced Soft Tissue Sarcomas
2007
Inhibition of DNA repair as a means of increasing the antitumor activity of DNA reactive agents
1997
Nonendocytic Delivery of Functional Engineered Nanoparticles into the Cytoplasm of Live Cells Using a Novel, High-Throughput Microfluidic Device
2012 StandoutNobel
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
Photodynamic Therapy in Dentistry
2007 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization
2007
Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide.
1993
Modulation of tumor cell response to chemotherapy by the organ environment
1994
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
2008
Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling
2009 Standout
DNA Topoisomerases: Structure, Function, and Mechanism
2001 Standout
Works of T. Cerny being referenced
Phase II studies of 4’-iodo-4’-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancers
1991
Pentostatin (2′-Deoxycoformycin, dCF) in Patients with Low-Grade (B-T-Cell) and Intermediate- and High-Grade (T-Cell) Malignant Lymphomas: Phase II Study of the EORTC Early Clinical Trials Group
1996
Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue
1994
Long-term results of a multicenter SAKK trial on high-dose ifosfamide and doxorubicin in advanced or metastatic gynecologic sarcomas
2006
Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC)
1988
Saturable metabolism of continuous high-dose ifosfamide with Mesna and GM-CSF: A pharmacokinetic study in advanced sarcoma patients
1999
Depletion of circulating cyst(e)ine by oral and intravenous mesna
1993
Phase I clinical and pharmacokinetic study of oral etoposide phosphate.
1995
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution
1989
Metabolism and pharmacokinetics of oral and intravenous ifosfamide
1991
A simple outpatient treatment with oral Ifosfamide and oral Etoposide for patients with small cell lung cancer (SCLC)
1989
Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy
1996
Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II study
1991
Patterns of Drug Resistance Parameters in Adult Leukemia
1995
[Autologous bone marrow transfusion in the treatment of adults with hematologic neoplasms. Experiences from Bern].
1989
High dose ifosfamide with mesna uroprotection.
1993
Thiodiglycolic acid is excreted by humans receiving ifosfamide and inhibits mitochondrial function in rats.
1998
Assessment of P-glycoprotein, glutathione-based detoxifying enzymes and O6-alkylguanine-DNA alkyltransferase as potential indicators of constitutive drug resistance in human colorectal tumors.
1991